Kuros Biosciences Ltd (CSBTF)
7.50
0.00 (0.00%)
USD |
OTCM |
May 07, 16:00
Kuros Biosciences Market Cap: 275.75M for May 7, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 07, 2024 | 275.75M |
| May 06, 2024 | 275.75M |
| May 03, 2024 | 261.04M |
| May 02, 2024 | 261.04M |
| May 01, 2024 | 261.04M |
| April 30, 2024 | 261.04M |
| April 29, 2024 | 332.74M |
| April 26, 2024 | 332.74M |
| April 25, 2024 | 332.74M |
| April 24, 2024 | 332.74M |
| April 23, 2024 | 332.74M |
| April 22, 2024 | 332.74M |
| April 19, 2024 | 307.00M |
| April 18, 2024 | 306.27M |
| April 17, 2024 | 306.27M |
| April 16, 2024 | 292.85M |
| April 15, 2024 | 319.50M |
| April 12, 2024 | 319.50M |
| April 11, 2024 | 315.46M |
| April 10, 2024 | 290.46M |
| April 09, 2024 | 253.69M |
| April 08, 2024 | 246.15M |
| April 05, 2024 | 248.18M |
| April 04, 2024 | 248.18M |
| April 03, 2024 | 240.82M |
| Date | Value |
|---|---|
| April 02, 2024 | 240.82M |
| April 01, 2024 | 235.31M |
| March 28, 2024 | 231.63M |
| March 27, 2024 | 229.79M |
| March 26, 2024 | 229.79M |
| March 25, 2024 | 229.79M |
| March 22, 2024 | 220.60M |
| March 21, 2024 | 220.60M |
| March 20, 2024 | 220.60M |
| March 19, 2024 | 220.60M |
| March 18, 2024 | 220.60M |
| March 15, 2024 | 220.60M |
| March 14, 2024 | 220.60M |
| March 13, 2024 | 220.60M |
| March 12, 2024 | 231.63M |
| March 11, 2024 | 221.15M |
| March 08, 2024 | 203.69M |
| March 07, 2024 | 203.69M |
| March 06, 2024 | 226.12M |
| March 05, 2024 | 220.60M |
| March 04, 2024 | 220.60M |
| March 01, 2024 | 220.60M |
| February 29, 2024 | 222.00M |
| February 28, 2024 | 222.00M |
| February 27, 2024 | 222.00M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
8.554M
Minimum
Dec 18 2019
332.74M
Maximum
Apr 22 2024
90.37M
Average
74.77M
Median
Dec 02 2020
Market Cap Benchmarks
| AC Immune SA | 232.41M |
| CRISPR Therapeutics AG | 4.523B |
| Addex Therapeutics Ltd | 9.769M |
| NLS Pharmaceutics Ltd | 5.952M |
| Molecular Partners AG | 119.92M |
Market Cap Related Metrics
| PS Ratio | 7.284 |
| PEG Ratio | -0.2668 |
| Price to Book Value | 4.084 |
| Price | 7.50 |
| Earnings Yield | -5.69% |
| PEGY Ratio | -0.2668 |